The novel piperazino-enaminone JOAB-40 reduced colitis severity in mice via inhibition tumor necrosis factor-α and interleukin-1β

Publication date: September 2021Source: Biomedicine & Pharmacotherapy, Volume 141Author(s): Maitham A. Khajah, Sanaa Hawai, Doreen E. Szollosi, Ashley Bill, Ola Ghoneim, Ivan Edafiogho
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research